Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Buchner

Showing results (151-160 of 207) with videos related to

Pageof 21
Sort By:
BJU International|December 7, 2023
Added value of randomised biopsy to multiparametric magnetic resonance imaging-targeted biopsy of the prostate in a contemporary cohortMichael Chaloupka, Nikolaos Pyrgidis, Benedikt Ebner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 27, 2020
PSMA-positive nodal recurrence in prostate cancer : Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysisNina-Sophie Schmidt-Hegemann, Alexander Buchner, Chukwuka Eze, et al.
Urologic Oncology|October 20, 2009
Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution seriesDerya Tilki, Boris Schlenker, Majnu John, et al.
Clinical and Translational Radiation Oncology|March 20, 2023
DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason scoreKristian Unger, Julia Hess, Vera Link, et al.
World Journal of Urology|October 20, 2024
Optimizing risk stratification for intermediate-risk prostate cancer - the prognostic value of baseline health-related quality of lifeThilo Westhofen, Alexander Buchner, Simon Lennartz, et al.
European Urology|March 4, 2008
GDNF-transduced Schwann cell grafts enhance regeneration of erectile nervesFlorian May, Kaspar Matiasek, Maurice Vroemen, et al.
Cancers|December 22, 2019
A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical ProstatectomyRun Shi, Xuanwen Bao, Joachim Weischenfeldt, et al.
World Journal of Urology|July 1, 2020
Impact of previous transurethral prostate surgery on health-related quality of life after radical prostatectomy: Does the interval between surgeries matter?Michael Chaloupka, Franka Figura, Philipp Weinhold, et al.
Patient Preference and Adherence|November 10, 2022
Gender Bias in Urology: How Do Patients Really Choose Their Urologist?Alexander Tamalunas, Philipp Lenau, Leo Federico Stadelmeier, et al.
Cancers|September 23, 2022
Radiomics for the Prediction of Overall Survival in Patients with Bladder Cancer Prior to Radical CystectomyPiotr Woźnicki, Fabian Christopher Laqua, Katharina Messmer, et al.
Pageof 21

Showing results (151-160 of 207) with videos related to

Sort By:
Pageof 21
BJU International|December 7, 2023
Added value of randomised biopsy to multiparametric magnetic resonance imaging-targeted biopsy of the prostate in a contemporary cohortMichael Chaloupka, Nikolaos Pyrgidis, Benedikt Ebner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 27, 2020
PSMA-positive nodal recurrence in prostate cancer : Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysisNina-Sophie Schmidt-Hegemann, Alexander Buchner, Chukwuka Eze, et al.
Urologic Oncology|October 20, 2009
Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution seriesDerya Tilki, Boris Schlenker, Majnu John, et al.
Clinical and Translational Radiation Oncology|March 20, 2023
DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason scoreKristian Unger, Julia Hess, Vera Link, et al.
World Journal of Urology|October 20, 2024
Optimizing risk stratification for intermediate-risk prostate cancer - the prognostic value of baseline health-related quality of lifeThilo Westhofen, Alexander Buchner, Simon Lennartz, et al.
European Urology|March 4, 2008
GDNF-transduced Schwann cell grafts enhance regeneration of erectile nervesFlorian May, Kaspar Matiasek, Maurice Vroemen, et al.
Cancers|December 22, 2019
A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical ProstatectomyRun Shi, Xuanwen Bao, Joachim Weischenfeldt, et al.
World Journal of Urology|July 1, 2020
Impact of previous transurethral prostate surgery on health-related quality of life after radical prostatectomy: Does the interval between surgeries matter?Michael Chaloupka, Franka Figura, Philipp Weinhold, et al.
Patient Preference and Adherence|November 10, 2022
Gender Bias in Urology: How Do Patients Really Choose Their Urologist?Alexander Tamalunas, Philipp Lenau, Leo Federico Stadelmeier, et al.
Cancers|September 23, 2022
Radiomics for the Prediction of Overall Survival in Patients with Bladder Cancer Prior to Radical CystectomyPiotr Woźnicki, Fabian Christopher Laqua, Katharina Messmer, et al.
Pageof 21